Wednesday, November 26, 2025 Time 18:00 Online, ICDG Grand Rounds, Bucharest, Romania 🔗https://us02web.zoom.us/j/3255268325... Head and Neck Squamous Cell Carcinoma (HNSCC) is the 6th most common type of cancer worldwide. Despite recent advances in diagnosis and conventional treatment options, HNSCC remains a devastating and difficult disease to treat. Despite

Watch a remarkable interview with one of the world's most acclaimed genomics researchers, who together with his collaborators helped to coin the term 'transcriptome' and whose insights and experiences offer an inspiring vision for the future of personalized medicine. He is internationally recognized for his discoveries in genomics and oncology research.

The Romanian Undiagnosed Rare Diseases Group of the Institute for Research-Development in Genomics (ICDG) has successfully concluded one of this year's most relevant initiatives dedicated to progress in applied genomics and personalized medicine. In partnership with the Center for Innovation in Education and Health (CieH) - UMF "Carol Davila", we brought together in Bucharest a

Tagged under: , , , ,

EUROPLAN 2025 Conference

November 18-19, 2025, at the UMF "Carol Davila" in Bucharest, the rare diseases community takes an important step forward: The EUROPLAN 2025 Conference marks the official launch of the Coalition for the update and implementation of the National Plan for Rare Diseases (NPRD). It is a key moment for the voices of patients, health professionals and decision-makers to meet in one place,

The Institute for Research-Development in Genomics (ICDG) was present at the MedMolMed International Conference in Chisinau, an interdisciplinary event dedicated to medicine, molecular and environmental sciences, bringing together researchers, clinicians and industry representatives from Romania, the Republic of Moldova and the region. The conference aims to strengthen scientific collaboration and accelerate the transfer of research results

TOP